Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

At least 400 researchers, physicians, activists, and other concerned citizens gathered here Monday night to rally for science and protest National Institutes of Health (NIH) funding cuts for HIV and ...

raising worries about HIV patients defaulting on treatment. (AP Photo/Jerome Delay} Show more Show less Unemployed 19-year-old South African Nozuko Majola walks with her children at her Umzimkhulu ...

Shares of Tesla Inc. fell again on Monday, as a negative turn in how Chief Executive Elon Musk is being viewed by consumers is fueling concern that sales will take a hit. There’s also a growing ...

It was the fourth straight drop for the main measure of the U.S. stock market’s health after it set an all-time high last week. The Nasdaq composite sank 1.4% as several influential Big Tech ...

New growth drivers, including updates from its extensive clinical pipeline, could help the stock to rebound ... company's Islatravir/Doravirine combination HIV treatment and its MK-0616 oral ...

The lawsuit, initiated in the Biden era, sought to treat the company as a stock exchange and was among a wave of enforcement actions targeting the regulatory gray areas surrounding cryptocurrency ...

LONDON (Reuters) - The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases including HIV and malaria in some of the world's poorest ...

PEPFAR’s humanitarian aid to combat HIV in Kenya was funded largely by USAID. “USAID started bringing ARVs free of charge,” said Palakudy. “We put all our children on ARVs and their lives ...

Wall Street is retreating from its record as a slide for Walmart weighs on U.S. stock indexes Thursday. The S&P 500 was down 0.6% in morning trading after setting all-time highs in each of the ...